1. India Stocks

  2. •

    Process industries

  3. •

    Chemicals: specialty
Chemcon Speciality Chemicals Ltd

Chemcon Speciality Chemicals Ltd

202.28
INR
-6.66
(-3.19%)
7.69EPS
24.21P/E
6.82BMarket Cap
Oct 24Next Earn
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
2026 Y
TTM
Revenue per Share
42.8
82.63
71.27
71.07
70.09
82.21
72.47
56.27
65.27
69.05
Basic EPS, GAAP
7.2
11.75
13.34
16.48
17.13
15.04
5.24
6.68
6.44
7.69
Free Cash Flow per Basic Share
1.66
-0.88
-1
9.69
6.56
-9.13
-8.43
7.85
8.83
- -
Dividend per Share
- -
- -
- -
- -
- -
4
- -
- -
- -
- -
Book Value per Share
14.64
26.49
39.96
96.56
113.89
124.86
130.06
136.68
131.89
- -
Tangible Book Value per Share
14.64
26.48
39.95
96.55
113.89
124.86
130.05
136.68
131.89
- -
Basic Weighted Avg Shares
37
37
37
34
37
37
37
37
37
37
Sales/Revenue/Turnover
1,568
3,027
2,611
2,432
2,567
3,012
2,655
2,061
2,391
2,529
Operating Margin (%)
27.45
20.88
25.29
31.12
29.62
20.7
6.24
10.89
8.03
9.99
Depreciation Expense
23
29
46
61
63
84
103
105
116
126
Net Income, GAAP
264
430
489
564
628
551
192
245
236
282
Effective Tax Rate (%)
34.94
29.68
24.75
25.85
25.29
25.68
26.9
26.23
26.16
26.01
Profit Margin (%)
16.83
14.22
18.71
23.19
24.44
18.29
7.23
11.86
9.87
11.14
Working Capital
269
605
1,109
2,443
2,982
2,201
2,895
2,714
2,675
- -
LT Debt
25
25
154
29
8
7
4
2
5
- -
Total Equity
536
970
1,464
3,537
4,172
4,574
4,764
5,007
4,831
- -
Return on Invested Capital (%)
- -
43.48
30.66
20.06
13.77
9.59
2.33
3.16
2.65
- -
Return on Capital (%)
- -
44.91
31.89
21.38
15.54
11.53
4.17
5.17
4.72
- -
Return on Common Equity (%)
- -
57.14
40.14
22.56
16.28
12.6
4.11
5.01
4.8
- -

Capital Structure

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
ST Debt
- -
531
- -
LT Borrowings
- -
1
- -
LT Finance Leases
- -
4
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
37
37
37
Market Capitalization
7,450
4,613
6,820

Working Capital

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
Total Current Assets
- -
3,460
- -
Cash, Cash Equivalents & STI
- -
657
- -
Accounts Receivable, Net
- -
635
- -
Inventories
- -
673
- -
Total Current Liabilities
- -
785
- -
Payables & Accruals
- -
- -
- -
ST Debt
- -
531
- -
Deferred Revenue
- -
- -
- -

Growth Rates

INR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
6.67%
-3.5%
Free Cash Flow
- -
-90.98%
12.55%
Net Income, GAAP
- -
-8.43%
-3.49%
Sales/Revenue/Turnover
- -
0.93%
16%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
455
526
544
549
2,061
2026
535
537
573
754
2,391
2027
665
- -
- -
- -
- -

Quarterly Earnings Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
1.47
1.73
2.4
1.08
6.68
2026
1.74
1.57
1.39
1.74
6.44
2027
2.99
- -
- -
- -
- -

Quarterly Dividends Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
2027
- -
- -
- -
- -
- -

Company Description

Company Profile APIChatGPT
CEO
Kamalkumar Rajendra Aggarwal
Full Time Employees
388
Sector
Process industries
Industry
Chemicals: specialty
Address
Onyx Business Center Vadodara GU India 390020
IPO Date
Sep 23, 2020
Website
cscpl.com
Similar Companies
Petkim Petrokimya Holding Anonim Sirketi (BIST:PETKM)
Albemarle Corporation (NYSE:ALB)
Linde plc (NASDAQ:LIN)
Gubre Fabrikalari T.A.S. (BIST:GUBRF)
IOL Chemicals & Pharmaceuticals Ltd. (NSE:IOLCP)
PI Industries Limited (NSE:PIIND)
Business
Chemcon Speciality Chemicals Limited operates as an Indian manufacturer specializing in pharmaceutical intermediates, silanes, and oilfield chemicals, including completion fluids. Founded in 1996 and headquartered in Vadodara, Gujarat, the company serves the pharmaceutical, silicone, electronics, and oilfield industries with products manufactured in compliance with GMP guidelines. Its core product portfolio includes pharmaceutical intermediates, completion brines, calcium bromide powder, zinc and calcium bromide mixtures, silanes, and specialty chemicals tailored for oilfield applications. The company holds ISO 9001:2015 and ISO 14001:2015 certifications for quality and environmental management. In recent developments, Chemcon completed the acquisition of Shivam Petrochem Industries’ business through a slump sale agreement valued at approximately INR 36 crore, enhancing its operational scale and product offerings. The firm expanded its production capacity of completion fluids to 18,000 tons per annum and commenced production of Completion Dry 14.2 (Calcium Bromide powder) with a capacity of 3,500 tons per annum. It appointed Mr. Neel Shah as an additional independent director and approved material related party transactions with the acquired Shivam Petrochem Industries, which is part of its promoter group. The company’s strategic focus remains on in-house process development for bromination and hydrochlorination technologies, maintaining leadership in the Indian market for products like Hexamethyldisilazane. Chemcon actively pursues new product development to support sustainable and efficient farming, alongside pharmaceutical and specialty chemical markets across India and selected international clients. Its sustained partnerships with major multinational pharmaceutical companies underline its strong market presence and commitment to high-quality product supply and timely delivery.